Brand Asset Management Group, Inc. Eli Lilly & CO Transaction History

Brand Asset Management Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $14,444 - $18,683	-80 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $9,685 - $11,656	-71 Reduced 47.02%	80 $13,000
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $173,420 - $204,129	-1,558 Reduced 91.16%	151 $20,000
Q1 2019 Apr 25, 2019	BUY	$111.31 - $131.02 $181,323 - $213,431	1,629 Added 2036.25%	1,709 $80,000
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $6,056 - $6,950	80 New	80 $7,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Brand Asset Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Brand Asset Management Group, Inc. with notifications on news.